Vilon (Lys-Glu or KE) is one of the most studied Khavinson bioregulatory peptides, developed at the Saint Petersburg Institute of Bioregulation and Gerontology. Vilon is classified as an immunomodulatory bioregulator — a dipeptide consisting of lysine and glutamic acid that targets immune system tissues. Research suggests these short peptides can penetrate the cell nucleus and interact with specific DNA sequences, modulating gene expression related to cell differentiation, proliferation, and apoptosis. Vilon has been shown to restore thymic function in aging organisms, promote T-cell differentiation, and enhance immune surveillance.
Key Data
Mechanism of Action
Vilon acts as a bioregulator by interacting with DNA and modulating gene expression in immunocompetent cells. It promotes differentiation of immune progenitor cells and enhances thymic function. As a short peptide, it can penetrate cell membranes and interact directly with chromatin.
Reported Benefits
All information is presented for Research Use Only (RUO). Not medical advice.